Alopecia Totalis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Conditions:   Alopecia Areata;   Alopecia Universalis;   Alopecia Totalis Intervention:   Drug: ATI 502 0.46% Topical Solution Sponsor:   Aclaris Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2018 Category: Research Source Type: clinical trials

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Condition:   Alopecia Intervention:   Drug: ATI-501 Sponsor:   Aclaris Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2018 Category: Research Source Type: clinical trials